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A flow induced Autoimmune 
Response and Accelerated 
Senescence of Red Blood cells in 
cardiovascular Devices
James p. Buerck1, Dustin K. Burke1, David W. Schmidtke3, trevor A. Snyder4,5, 
Dimitrios papavassiliou  1 & edgar A. o’Rear1,2*
Red blood cells (RBcs) passing through heart pumps, prosthetic heart valves and other cardiovascular 
devices undergo early senescence attributed to non-physiologic forces. We hypothesized that 
mechanical trauma accelerates aging by deformation of membrane proteins to cause binding of 
naturally occurring igG. RBcs isolated from blood of healthy volunteers were exposed to high shear 
stress in a viscometer or microfluidics channel to mimic mechanical trauma and then incubated with 
autologous plasma. increased binding of igG was observed indicating forces caused conformational 
changes in a membrane protein exposing an epitope(s), probably the senescent cell antigen of 
band 3. The binding of immunoglobulin suggests it plays a role in the premature sequestration and 
phagocytosis of RBcs in the spleen. Measurement of igG holds promise as a marker foreshadowing 
complications in cardiovascular patients and as a means to improve the design of medical devices in 
which RBcs are susceptible to sublethal trauma.
Flow represents an important stimulus of mechanosensing for many fundamental biological processes. That is 
particularly true for certain functions of the circulatory system. The action of shearing blood flow on vessel 
walls causes the release of nitric oxide (NO), drives formation of catch bonds during leukocyte rolling, stimu-
lates expression of fibrinolytic trigger tPA, and results in reduced presentation of inflammatory molecules1–6. In 
developmental biology, flow affects gene expression and cell differentiation setting them, for example, on a path 
to formation of distinct heart chambers7 and may play an additional role in development by determining arte-
rial or venous cell identity8. Through such mechanisms, the physical action of shear stress triggers biochemical 
responses important to functioning and development of the circulatory system.
Shear stress is also important in the initiation and progression of certain pathologies. In particular, flow 
has been integral to understanding of atherosclerosis and the localization of plaques. Disturbed flow promotes 
increased expression of pro-inflammatory species like E-selectin and VCAM-19,10. Mechanical trauma, a pathol-
ogy distinctively attributable to flow, occurs when components of blood encounter non-physiologic forces during 
extracorporeal circulation with consequences for platelets11,12, white cells13,14 and von Willebrand Factor, vWF15,16 
in addition to erythrocytes(RBCs).
Once a major concern in mechanical trauma, hemolysis has become less of an issue with design improvements 
of prosthetic heart valves and heart pumps. A less apparent manifestation of harm is reduced ability of injured 
RBCs to survive the microcirculation. As early as 1962, sublethal damage was evident in animal studies of extra-
corporeal circulation by shortened circulatory half-lives and anemia17. While flow in contemporary prosthetic 
heart valves causes little or no hemolysis, the stresses present do reduce cell lifespans by approximately 20%18. 
In similar fashion, the high shear environment in ventricular assist devices (VADs) has been linked to markedly 
abridged circulatory lifespans for RBCs19. This is important because accelerated removal contributes to anemia 
for an individual and/or means an added metabolic load to replace the lost cells. Loss of RBCs has been attributed 
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to reduced deformability and early capture in the spleen20. In vitro experiments by Velker21 in 1977 first estab-
lished stiffness of RBCs after shear exposure, a result later confirmed by a number of other groups22–26.
Sublethal mechanical trauma is in fact known to cause a shortened mean circulatory lifespan for red blood 
cells. Nanjappa27 found that the half-life of re-infused Cr51-labelled RBCs in the dog decreased with the length of 
exposure time by 22–60% after low shear stress ex vivo (~9 Pa). This research observation fits with clinical findings 
for circulatory lives of RBCs from prosthetic heart valve patients and ventricular assist devices. Compared to con-
trols (122 ± 23 days), patients with biologic heart valves (103 ± 15 days) and mechanical valves (98.8 ± 23 days) 
have shorter mean RBC lifespans28. Likewise, mean RBC lifespans for patients on continuous flow left ventricular 
assist devices have been reported to be as low as 30 days19. This premature elimination of cells after blood trauma 
indicates more subtle, sublethal forms of damage may be involved and hints at underlying mechanisms similar to 
those effecting removal of the senescent RBC.
Increased rigidity after non-physiological shear is a characteristic shared with senescent red blood cells that 
contributes to their routine removal after a normal 120 day lifespan20,29. Years ago Kameneva recognized the 
similarity between cells naturally aged and those exposed to mechanical stress30. To our knowledge though, no 
group has explored links between shear stress and other widely held theories related to senescence. We considered 
that mechanisms for physiologic elimination of old RBCs might offer insights into the pathology of mechanical 
trauma.
Rubin has suggested that the two main models of RBC aging are eryptosis, a variation of apoptosis, and band 
3 clustering31. These theories tend to focus on biochemical aspects that may act in concert with altered deforma-
bility32. That is, stiff cells will move through the spleen more slowly, affording greater opportunity for recognition 
of opsonins by macrophages and phagocytosis. One theory for aging involves attachment of methemoglobin to 
the interior surface of the RBC membrane or other stimulus to promote aggregation of the integral structural 
transmembrane protein band 3 (SLC4A1, a solute carrier family 4, anion exchanger, member 1)33,34; according 
to this theory, subsequent binding of naturally occurring antibodies(NAbs) to these band 3 clusters promotes 
capture of the cell in the spleen35.
Band 3 contains a senescent antigen, identified by Kay, that has epitopes for NAbs36,37. Since the senescent anti-
gen is present on band 3 in young cells38, a key step during aging must somehow bring about greater availability. 
That may occur by aggregation, enzymatic modification or molecular rearrangement. It is conceivable that defor-
mation of a young cell due to flow will induce accessibility. For example, conformational changes in membrane 
proteins might expose the senescent antigen39 as a result of shear. Moreover, it seems plausible that enhanced 
mobility of membrane proteins during shear could facilitate band 3 clustering and conformational change. By 
attaching latex beads to the RBC membrane and observing single cells during “tank tread” flow in the rheoscope, 
Fischer demonstrated relative motion within the surface of the membrane40. Such motion should increase the 
interaction of molecules of band 3 with greater prospects for aggregation and NAbs binding.
We have shown that binding of autologous immunoglobulin G(IgG) to RBCs occurs at exposure times and 
stress levels found in cardiovascular devices and conclude that it may be a contributing factor to premature 
removal of red blood cells in patients with these devices. Externalization of phosphatidylserine (PS) on the outer 
surface of the cell and eryptosis, another prospective basis for removal of senescent RBCs39,41,42, was not found in 
the present study to be a significant factor.
Results
igG binding to RBc membrane as a result of varying exposure time/shear stress to washed 
RBc. Nonphysiologic levels of shear produced in vitro, through use of two shear methods (a microfluidics 
channel and a viscometer, Fig. 1, described in Materials and Methods), cause autologous IgG to bind to RBCs. 
Typical findings from flow cytometry (Fig. 2) indicate a significant increase in IgG-positive RBCs after flow 
through the microfluidics channel and subsequent incubation with autologous plasma. Positive events in the 
upper right quadrant represent RBCs with fluorescently tagged antibody to human IgG. For the specific set of 
samples in Fig. 2(c–e) with exposure times to high shear of 0 (control low shear channel), 5 and 15 msec respec-
tively at a wall shear rate of 100,000 s−1, the percent of cells binding are respectively 0.3%, 3.1% and 13.6%, after 
excluding microparticles and cellular debris by gating specifically for events of size (forward scatter, FSC) and side 
Figure 1. Two methods of shear were used for varying testing conditions. (a) The effect of stress magnitude 
was examined with a viscometer designed for uniform shear with G1 = G2, G3 was machined to give a volume 
average shear equal to that in the concentric cylinder and cone-and-plate sections. (b) The high shear region in 
the microfluidic channels were varied in length, from 0.7 to 11.6 mm, to vary time of shear to RBCs at a shear 
rate of 100,000 s−1. A control for the microfluidic devices with no high shear region was also used.
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scatter (SSC) within the range for RBCs. The fraction of cells binding IgG rises steadily in a statistically significant 
way (p < 0.001) as the exposure time is increased (Fig. 2f) as well as the magnitude of shear stress itself (Fig. 2g, 
see below). Average percentage of cells with antibody increases from a control value of 1.0% up to a value of 15.9% 
at the maximum exposure time tested, across the combined average of all individual tests. This control represents 
testing of washed RBCs, not run through a channel. Values for the straight channel lacking a high shear region are 
similar at 1.6 ± 0.5%. Flow cytometry results are also suggestive (p = 0.07) of greater damage to IgG-positive cells 
Figure 2. The general flow cytometry methods used in determining percent of cells which fluoresced are 
shown. Flow cytometry results were collected via the BD Accuri C6 flow cytometer then further analyzed 
using FlowJo software. (a) In every case the events were first gated for presence of CD235a (FITC conjugated), 
(b) then additionally gated according to FSC-SSC to exclude any cellular debris or microparticles. (c–e) 
Representative output from the BD Accuri C6 Flow Cytometer for RBCs in a control, 5 msec and 15 msec 
high shear exposure time samples, respectively from left to right. Each y-axis corresponds to fluorescence 
intensity from the FL4-anti-IgG Alexa Fluor 647 conjugate and the x-axis shows FSC, relating to event size. 
Each individual test was run for 75,000 total RBCs. (f) The percent of CD235a + RBCs with IgG attached grew 
with duration of shear after a single exposure in a microfluidics channel at 100,000 s−1 (n = 5, p < 0.001). (g) 
The fraction of CD235a + RBCs binding IgG increased with the magnitude of the stress in the viscometer for 
2 min. (n = 5, p < 0.001) Data presented in (f,g) is the average ± standard error, with * representing significance 
according to post hoc Tukey HSD. Additional tests for Alexa Fluor 647 Mouse IgG2a, k Isotype Ctrl Antibody 
to account for the possibility of non-specific binding was omitted in (f,g), having on average 0 ± 0.1% average 
binding across all tests.
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with higher average fluorescence occurring as exposure time increased (Fig. 3a). Confocal microscopy(Fig. 3b) of 
cells incubated with the same probes for CD235a and IgG confirmed the presence of immunoglobulin on RBCs 
after shear. 50 cells in each experiment(n = 3), control and shear samples (10 msec exposure to 100,000 s−1), were 
analyzed using FIJI ImageJ software and RBCs with detectable fluorescence above the background were recorded. 
Analysis of fluorescence in confocal microscopy also supported flow cytometry results, yielding a higher average 
fluorescence intensity of positive cells recorded after 10 msec shear at 100,000 s−1 (Fig. 3c). Fluorescence intensity 
of anti-IgG Fc Alexa Fluor 647 positive sheared cells is much higher than that for anti-IgG positive control cells, 
approximately 3 times greater according to confocal microscopy images.
In general, the effects of mechanical trauma on blood cells have been found to depend on both shear stress 
and exposure time. We carried out experiments with a viscometer to investigate immunoglobulin attachment as 
a function of shear stress over the range of 0–130 Pa. Binding of IgG also depends on magnitude of shear stress(-
Fig. 2g). The results for unsheared control sample shows on average 1.1% cells testing positive for IgG, similar 
to the value for the zero shear control in the exposure time experiments. Extent of binding increases with shear 
stress starting at 0 Pa with a value of 1.1% for a 2 min exposure and rising to 16.0% at 130 Pa.
phosphatidylserine exposure on RBcs after exposure to shear stress. For the red blood cell, 
externalized PS marks the cell for eryptosis41. Eryptosis potentially offers an alternative mechanism to explain 
Figure 3. An average increase in fluorescence of RBCs which presented anti-IgG Fc Alexa Fluor 647 
fluorescence was presented by data collected via flow cytometry and in collected confocal microscopy images 
of live cells in media. (a) The average fluorescence of the control flow cytometry results was found. That value 
was then taken as a reference for the relative increase in fluorescence recorded by flow cytometry(n = 5). (b) 
Confocal microscopy images shown are from left to right accordingly, anti-CD235a fluorescence, anti-IgG 
Fc fluorescence, and an overlay of the two images to show binding presence across the RBC. (c) Confocal 
microscope images were further analyzed by measuring the average intensity above background noise. 
Fluorescent intensity is presented as mean fluorescence above the background of the image.
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elimination of mechanically traumatized cells. Fluorescently labelled Annexin V was used with flow cytometry to 
investigate the presence of externalized PS on cells and microparticles (Fig. 4a).
Only a small fraction of cells(1–3%) bound Annexin V and the concentration does not increase over the 
control level with exposure time(Fig. 4b). While the number of RBCs expressing PS does not increase, those that 
do are susceptible to greater exposure of PS with shear over the range of 0–15 msec(Fig. 4c). Results shown are 
the fluorescence increase, relative to the control average. Cells which expressed Annexin V fluorescence had on 
average 3.0 times greater FL4 (Alexa Fluor 647) values after 15 msec exposure in microfluidic channels than the 
control.
Discussion
The importance of mechanical forces on cells to aspects of the immune system has recently been reviewed6. In this 
study, immunoglobulin binding increased with the magnitude of the stress and length of exposure (Fig. 2f,g). The 
results of this sublethal damage follow well-known trends for hemolysis. Findings provide evidence for a unique 
autoimmune response to shear forces and a new insight to RBC removal after mechanical trauma. The binding of 
IgG to the membrane mirrors that for senescent RBCs. Old RBCs have high levels of immunoglobulin G which 
serves as an opsonin, marking the cells for erythrophagocytosis by macrophages and neutrophils in the spleen43. 
The level of bound antibodies increases markedly as the cell ages. Franco found that biotinylated RBCs, though 
present in a low concentration, had significantly higher levels of IgG after 126 days in the human44. Similar exper-
iments in the dog with biotinylated eRBCs showed a seven fold increase in bound naturally occurring antibodies 
(NAbs)45. NAbs binding to band 3 in the RBC is known and has been proven to promote phagocytosis of the 
cell46. To explain the underlying process determining the effect of aging, Low proposed that the formation and 
attachment of methemoglobin to the interior surface of the cell membrane promoted IgG binding via aggregation 
of transmembrane protein band 333. We hypothesize that deformation of the cell by shear results in conforma-
tional or translational motion of band 3 to expose epitopes for NAbs and an autoimmune response similar to that 
from senescence. The concept is illustrated in Fig. 5.
The effects of shear on RBCs found in this research might also be compared to autoimmune hemolytic ane-
mias, characterized by the attachment of immunoglobulin IgG and/or IgM47. Binding of immunoglobulins G 
and/or M to RBCs is the hallmark of autoimmune hemolytic anemia, “not an uncommon” clinical condition 
according to Chaudhary, with ultimate loss of RBCs by complement activation and the reticuloendothelial sys-
tem. IgG, a relatively poor activator of the complement system47, leads primarily to removal of RBCs in the 
spleen48. With loss of RBCs and putative IgG binding, the cardiovascular patients groups mentioned above can be 
said to have a mechanically induced auto-immune hemolytic anemia.
With the prospect of an immune component to RBC removal, the relative importance of RBC deformability 
and IgG opsonization remains an open question. Poor RBC deformability has long been recognized for both 
senescent and mechanically traumatized RBCs. Working independently, Sutera and Shiga observed the flow of 
density separated, older cells in the rheoscope and reported increased stiffness49,50 and many groups have found 
decreased deformability after non-physiologic shear of a non-segregated population of RBCs. Stiff red blood cells 
are challenged by the small dimensions of the trabeculated surfaces in the spleen. Notably, perfusion of an isolated 
rabbit spleen ex vivo with a mixture of sheared (<10 N/m2) and unsheared RBCs in sera demonstrated selective 
removal of the traumatized cells51. Some clinical work supports the significance of altered rheology. Abridged 
RBC lifespans noted above for prosthetic heart valve patients correspond to reports of increased rigidity of red 
blood cells52,53. Moreover, decreasing filterability of RBCs isolated from valve patients has been correlated with 
lower whole blood hematocrit53, a result possibly due to bound proteins54. Another aspect of the RBC survival 
in the circulation is opsonization and phagocytosis in the spleen43. While reduced RBC deformability will slow 
passage through the spleen and thereby facilitate recognition of opsonins, it does not, at least in vitro, promote 
phagocytosis32. In studying diamide treated RBCs, Safeukui concluded splenic sequestration did not depend on 
Figure 4. Average percent of cells which bind Annexin V Alexa Fluor 647 was also studied after shear stress in 
microfluidic channels. (a) Similar to the FC detection of IgG presence, presence of PS on RBCs was determined 
using first gates for CD235a FITC fluorescence and on event size by FSC-SSC. (b) The fraction of red blood 
cells with externalized PS as determined by binding of fluorescently labeled Annexin V was small and did 
not increase with duration of shear (n = 5). (c) The average fluorescence of the control flow cytometry results 
was found. That value was then taken as a reference for the relative increase in fluorescence recorded by flow 
cytometry. The amount of PS fluorescence in the positive subpopulation did increase significantly with exposure 
time(n = 5, p = 0.01).
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reduced membrane deformability and suggested aggregation of membrane proteins such as band 3 led to splenic 
entrapment29. Thus, rheology and immunology seemingly act together to set circulatory lifespan of senescent and 
traumatized RBCs.
Some have suggested exposure of phosphatidylserine and apoptosis-like processes, eryptosis, as a mechanism 
for senescence, although this view no longer seems to be held generally41,55 and, in fact, PS levels are not high 
in aged RBCs44. Likewise, at 1–2%, only a very small fraction of RBCs displayed phosphatidylserine after shear 
(Fig. 4b), even at the longest exposure. However, the extent of PS exposed in this subpopulation did grow with 
exposure time (Fig. 4c). The nature of this group of RBCs is unclear, and while they are affected by shear, they do 
not appear to be a result of mechanical trauma since the fraction of PS positive cells did not increase with expo-
sure time (Fig. 4b).
As RBCs age, they also lose membrane and hemoglobin by shedding vesicles or microparticles, which has 
been suggested as a mechanism to rid the cell of harmful species56. Older cells are known to be smaller. Unsheared 
control cells binding IgG were smaller than other cells in the sample and presumably represented a senescent sub-
population. Interestingly, those sheared cells binding IgG were also a smaller size sub-population. Thus, senescent 
and mechanically traumatized cells share displayed increased IgG binding, reduced deformability, smaller size 
and microparticle shedding.
While ventricular assist devices and prosthetic heart valves extend the lives of many patients who suffer with 
cardiovascular problems, they operate with regions of flow where blood experiences high shear stresses57 similar 
to conditions yielding the results of Fig. 2f. The stresses can damage cells leading to complications like anemia and 
thrombosis so that the discovery of increased IgG binding to RBCs after shear may have important clinical appli-
cations. Currently, a good indicator of sublethal damage is not available, though assays for bound IgG or possibly 
another chemical marker of senescence38 may meet that need. IgG should be feasible since its measurement on 
RBCs is already important to monitoring of patients with autoimmune hemolytic anemia6. Thus, it could prove to 
be an effective method for assessing how well patients adapt to medical devices with extracorporeal flow and for 
anticipating which individuals are more likely to suffer a complication like stroke, thrombosis or gastrointestingal 
bleeding.
An ongoing challenge is to translate flow characteristics from computer simulations into predictions of meas-
urable blood damage. IgG binding should be valuable to engineers as a guide to further improvements in device 
design to reduce stress well below levels discernible by hemolysis. Linking flow history of blood to an experimen-
tal measure of the cell damage could facilitate making further improvements in design and operating conditions. 
In particular, assessing the level of sublethal damage to cells is essential to progress in addressing abbreviated 
RBC lifespans.
Figure 5. A visualization of the RBC membrane and the proposed response to shear stress by some change 
in Band 3 with IgG. Glycophorin A (GPA), Rhesus (Rh) protein, CD47, and ankyrin included as relevance 
to their inclusion in the Band 3 complex and anchoring to the RBC spectrin network. Lipids sphingomyelin, 
phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine and PS shown to demonstrate lipid 
bilayer asymmetry. (a) Healthy RBC membranes exhibit a continuous sorting of phospholipids to maintain 
consistency and peak performing proteins. The Band 3 protein exists commonly as a tetramer within a protein 
complex tied into the spectrin network through the protein ankyrin. Band 3 also exists as a free moving dimer. 
(b) Postulated conformational changes of Band 3 after shear exposes the senescent cell antigen and leads to 
binding of naturally occurring antibodies.
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Materials and Methods
Blood collection. Venous blood was collected from healthy adult donors (n = 10), aged 18–64, in 3.2% 
sodium citrate vacutainers (VWR). All blood collection was done following procedures approved by the 
University of Oklahoma Institutional Review Board (IRB). Donors were informed of the overall goal of our 
research prior to donations and informed consent was obtained. Blood donations were kept confidential with no 
identifying documents. Experimental procedures were also performed according to approved methods set and 
approved by the IRB at the University of Oklahoma. All RBCs were isolated with a series of three isotonic saline 
solution (147.5 mM NaCl) washes, followed by re-suspension in a modified Ringer’s Solution (147.5 mM NaCl, 
4 mM KCl, 2.25 mM CaCl2, and 10 mM glucose, with 0.05 g/L of Human Serum Albumin). Post initial centrifuge 
of donor blood, plasma was collected via Pasteur pipette and collected for later use. With each isotonic wash, 
supernatant and buffy coat were removed by Pasteur pipette. After re-suspension in modified Ringer’s solution, a 
Moxi Z Cell Counter (ORFLO) was used to determine RBC concentration and allowed for adjusting to an overall 
sample concentration of 5 × 109 cells/mL (~37% hematocrit).
Shear methods in vitro. Two methods were used to expose RBCs to shear in this study—a viscometer 
and microfluidics channels (Fig. 1). Both approaches involved shearing cells in a controlled environment for a 
given period of time. In each case, mechanically traumatized cells were collected for testing following shear with 
unsheared cells providing a control. The use of a specially designed Hercules Hi-Shear Couette viscometer with 
R = 1.9825 cm, G1 = G2 = 0.06 mm and G3 = 0.8 mm (Kaltec Industries) gave initial results. Cone-and-plate and 
parallel plate end regions of the bob were machined to match the shear stress in the concentric cylinder portion of 
the sample. Using this method the shear stress was varied while maintaining exposure time at two minutes. Shear 
stresses tested with the Couette viscometer were over the range of 10–130 Pa. Each test used an aliquot of 4.1 mL 
of the washed RBC suspension prepared as described above.
The second shear method involved the use of microfluidic channels to mimic more closely the flow con-
ditions of high stress, short exposure times exhibited by VADs and prosthetic heart valves. The microfluidic 
shearing devices contained a constricted region that was designed to expose RBCs transiently (i.e. msec) to high 
shear conditions58. The cross-section of the constricted region was 45 μm wide x 60 μm tall, and the constric-
tion length was varied from 0.7 to 11.6 mm to provide different high shear exposure times.Channels were pre-
pared from poly-dimethyl siloxane (PDMS), using a Sylgard® 184 Silicone Elastomer kits (Dow Corning), as 
previously described58. Before running, the channel and tubing were charged with the modified Ringers solu-
tion. Flow through channels was created using an approximately 3 cm segment of tubing (1.57 mm I.D., Silastic® 
Laboratory) attached to a 1 mL syringe in a syringe pump. A constant shear environment on the cells is accom-
plished by maintaining a constant flow rate through the channels. A straight channel microfluidic device (1500 
μm wide x 60 μm tall) with no constriction and low shear was used as an additional control.
flow cytometry analysis. Flow cytometry data was collected using a BD Accuri C6 Flow Cytometer (BD 
Sciences). RBC positive events were identified foremost by anti-CD235a-FITC (glycophorin A; eBioscience) 
binding.
igG binding. Immediately following shear exposure, the cells were collected and suspended to a concen-
tration of 106/mL and then incubated for 45 min at 37 °C with autologous plasma to permit autoantibody IgG 
binding to the cell surfaces. Afterwards, cells resuspended at a concentration of 106/mL were incubated for an 
additional 60 min with both 5 μL (0.25 μg)/test mouse anti-CD235a-FITC (eBioscience) and 5 μL/ test mouse 
anti-IgG Fc Alexa Fluor 647(Biolegend) conjugates before analysis with flow cytometry or fluorescent microscopy. 
To account for non-specific contributions, Alexa Fluor 647 Mouse IgG2a, k Isotype Ctrl Antibody (Biolegend) 
was used, with no apparent binding present in control or experimental tests.
phosphatidylserine externalization. In addition to anti-CD235a, a second probe used was a marker 
for phosphatidylserine, Annexin V Alexa Fluor 647(ThermoFisher Sci). Following shear stress, cells were 
suspended to 106 cells in 0.5 mL Ringers solution. The cellular suspension was then labeled with 5 µL of 
CD235a-FITC(eBioscience) and 5 µL Annexin V Alexa Fluor® 647 according to company protocol. After a 
60 min. incubation period at 37 °C, cell and microparticle samples in media were then analyzed by flow cytometry.
confocal microscopy. Confocal microscopy images were taken with a Leica SP8 scanning confocal micro-
scope at the Samuel Roberts Noble Microscopy Laboratory. Fresh live cells in media were imaged after labeling 
as described above for flow cytometry. Images were then processed using FIJI-ImageJ software to remove back-
ground noise and conduct further analysis. In each of n = 3 experiments, 50 cells were evaluated for increased flu-
orescence above background noise. Cells determined positive for anti-IgG Fc Alexa Fluor 647 were then further 
evaluated for amount of fluorescence above background by measuring the mean fluorescence.
Statistics. In each experiment, significance was assessed using Excel statistical analysis ToolPak one-way 
ANOVA with further post hoc Tukey honest significant difference (HSD). The Tukey HSD tests were used to 
determine specifically how many of the individual tests showed significance when compared directly. Significance 
was defined as p < 0.05. All average values are reported as the mean ± standard error.
Data availability
Data sets generated for this study are available from the corresponding author on reasonable request.
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